| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
283 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 12
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-09-01 |
4 |
OE |
$32.25 |
$1,290,000 |
D/D |
40,000 |
889,119 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-10-01 |
4 |
OE |
$32.25 |
$645,000 |
D/D |
20,000 |
871,309 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-10-12 |
4 |
OE |
$32.25 |
$645,000 |
D/D |
20,000 |
871,309 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-11-02 |
4 |
OE |
$32.25 |
$658,577 |
D/D |
20,421 |
872,825 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-11-05 |
4 |
OE |
$32.25 |
$631,423 |
D/D |
19,579 |
872,004 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-12-04 |
4 |
OE |
$32.25 |
$1,290,000 |
D/D |
40,000 |
893,499 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2010-01-04 |
4 |
OE |
$32.25 |
$1,290,000 |
D/D |
40,000 |
893,499 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-10 |
4 |
S |
$32.34 |
$37,967 |
D/D |
(1,174) |
840,148 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-09-15 |
4 |
S |
$33.32 |
$718,026 |
D/D |
(21,200) |
330,399 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-16 |
4 |
S |
$34.25 |
$289,584 |
D/D |
(8,455) |
831,693 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-01-12 |
4 |
S |
$34.44 |
$46,150 |
D/D |
(1,340) |
820,828 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-04-17 |
4 |
OE |
$34.86 |
$232,516 |
D/D |
6,670 |
841,424 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-04-17 |
4 |
D |
$34.94 |
$345,242 |
D/D |
(9,881) |
831,543 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-17 |
4 |
OE |
$34.98 |
$434,307 |
D/D |
12,385 |
827,763 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-02-15 |
4 |
AS |
$35.01 |
$350,100 |
D/D |
(10,000) |
311,511 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-03-17 |
4 |
D |
$36.00 |
$708,084 |
D/D |
(19,669) |
808,094 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-01-16 |
4 |
S |
$36.89 |
$184,339 |
D/D |
(4,997) |
815,831 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-07-10 |
4 |
S |
$36.93 |
$43,319 |
D/D |
(1,173) |
850,370 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-02-26 |
4 |
D |
$36.98 |
$362,182 |
D/D |
(9,794) |
821,322 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-10-16 |
4 |
S |
$37.85 |
$760,875 |
D/D |
(20,100) |
340,299 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-03-10 |
4 |
AS |
$38.35 |
$341,583 |
D/D |
(8,907) |
311,511 |
|
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-02-26 |
4 |
OE |
$38.56 |
$220,370 |
D/D |
5,715 |
831,116 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2009-07-16 |
4 |
S |
$38.96 |
$48,739 |
D/D |
(1,251) |
849,119 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-11-09 |
4 |
AS |
$40.01 |
$789,263 |
D/D |
(19,725) |
370,674 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2006-11-14 |
4 |
AS |
$42.25 |
$817,785 |
D/D |
(19,350) |
381,324 |
0 |
- |
|
283 Records found
|
|
Page 6 of 12 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
